No Data
No Data
Capital One Financial Maintains Fennec Pharmaceuticals(FENC.US) With Buy Rating, Maintains Target Price $17
Capital One Financial analyst Naureen Quibria maintains $Fennec Pharmaceuticals(FENC.US)$ with a buy rating, and maintains the target price at $17.According to TipRanks data, the analyst has a success
Fennec Pharmaceuticals(FENC.US) Officer Sells US$16,433.56 in Common Stock
$Fennec Pharmaceuticals(FENC.US)$ Officer Raykov Rosty sold 2,431 shares of common stock on Jun 3, 2024 at an average price of $6.76 for a total value of $16,433.56.Source: Announcement What is statem
Fennec Pharmaceuticals Inc.'s (NASDAQ:FENC) 26% Dip In Price Shows Sentiment Is Matching Revenues
The Fennec Pharmaceuticals Inc. (NASDAQ:FENC) share price has fared very poorly over the last month, falling by a substantial 26%. Longer-term shareholders would now have taken a real hit with the
Is Fennec Pharmaceuticals (NASDAQ:FENC) A Risky Investment?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' When we think about how risky a company is, we always like
Fennec Pharmaceuticals Is Maintained at Buy by Craig-Hallum
Fennec Pharmaceuticals Is Maintained at Buy by Craig-Hallum
Express News | Craig-Hallum Maintains Buy on Fennec Pharmaceuticals, Lowers Price Target to $17